These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10546043)

  • 1. Impaired fasting glucose and cardiovascular disease.
    Perry IJ
    Diabetes Care; 1999 Nov; 22(11):1919-20. PubMed ID: 10546043
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of factors differentially associated with isolated impaired fasting glucose and isolated post-load impaired glucose tolerance: the Hong Kong Cardiovascular Risk Factor Study.
    Thomas GN; Schooling CM; McGhee SM; Ho SY; Cheung BM; Wat NM; Janus ED; Lam TH;
    Eur J Endocrinol; 2006 Oct; 155(4):623-32. PubMed ID: 16990663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of diabetes and impaired fasting glucose in Costa Rica: Costa Rican National Cardiovascular Risk Factors Survey, 2010.
    Wong-McClure R; Gregg EW; Barcelo A; Sanabria-Lopez L; Lee K; Abarca-Gomez L; Cervantes-Loaiza M; Luman ET
    J Diabetes; 2016 Sep; 8(5):686-92. PubMed ID: 26516694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease.
    Heldgaard PE; Olivarius Nde F; Hindsberger C; Henriksen JE
    Diabet Med; 2004 Apr; 21(4):363-70. PubMed ID: 15049940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose.
    Liu J; Joshi D; Sempos CT
    Appl Physiol Nutr Metab; 2009 Apr; 34(2):136-42. PubMed ID: 19370043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting blood glucose and risk of cardiovascular disease.
    Balkau B; Jarrett RJ; Pyörälä K; Eschwège E
    Diabetes Care; 1999 Aug; 22(8):1385-7. PubMed ID: 10480797
    [No Abstract]   [Full Text] [Related]  

  • 8. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT; Cockram CS; Chan JC
    J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
    Sanusi H
    Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired fasting glucose in hypertensive patients: prevalence and cross-sectional analysis of associations with cardiovascular disease.
    Tziomalos K; Spanou M; Baltatzi M; Efthymiou E; Psianou K; Papastergiou N; Iliadis F; Didangelos TP; Savopoulos C; Hatzitolios AI
    Diabetes Technol Ther; 2013 Jun; 15(6):475-80. PubMed ID: 23544673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From metabolic normality to cardiometabolic risk factors in subjects with obesity.
    Bobbioni-Harsch E; Pataky Z; Makoundou V; Laville M; Disse E; Anderwald C; Konrad T; Golay A;
    Obesity (Silver Spring); 2012 Oct; 20(10):2063-9. PubMed ID: 22421925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and metabolic features of subjects with glucose intolerance and high fasting glucose levels].
    Arteaga Llona A; Pollak F; Robres L; Velasco N
    Rev Med Chil; 2009 Feb; 137(2):193-9. PubMed ID: 19543640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
    Tominaga M; Eguchi H; Manaka H; Igarashi K; Kato T; Sekikawa A
    Diabetes Care; 1999 Jun; 22(6):920-4. PubMed ID: 10372242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood glucose is associated with chronic kidney disease in subjects with impaired glucose tolerance, but not in those with impaired fasting glucose.
    Wang C; Song J; Sun Y; Hou X; Chen L
    J Diabetes; 2014 Nov; 6(6):574-6. PubMed ID: 24889516
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucose.
    Crook MA; Goldsmith L; Ameerally P; Lumb P; Singh N; Miell J; Russell-Jones D
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):606-8. PubMed ID: 12564845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.
    Andreozzi F; Succurro E; Mancuso MR; Perticone M; Sciacqua A; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2007 Oct; 23(7):547-50. PubMed ID: 17311284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.